Medicare Enrolled

Dr. Mandy Robertson, MD

Hematology · Olympia, WA
Consulting-driven
700 LILLY RD NE, Olympia, WA 98506
3609237000
In practice since 2006 (20 years)
NPI: 1790730174 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Robertson from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Robertson? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Robertson

Dr. Mandy Robertson is a hematology specialist in Olympia, WA, with 20 years of NPI registration.

Between the years covered by Open Payments, Dr. Robertson received a total of $10,547 from 42 pharmaceutical and/or device companies across 132 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Robertson is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice $10,547 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$10,547
Total received (2018-2024)
Avg $1,758/year across 6 years
Top 28% in WA for hematology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
42
Companies
132
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$6,700 (63.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,264 (30.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$583 (5.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,478
2022
$54
2021
$44
2020
$141
2019
$659
2018
$7,172

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$287
GlaxoSmithKline, LLC.
$232
Novartis Pharmaceuticals Corporation
$216
ABBVIE INC.
$185
PFIZER INC.
$166
Genmab U.S., Inc.
$134
Merck Sharp & Dohme LLC
$133
Janssen Biotech, Inc.
$100
Celgene Corporation
$78
Tempus AI, Inc
$63
Incyte Corporation
$63
Lilly USA, LLC
$60
E.R. Squibb & Sons, L.L.C.
$58
Stemline Therapeutics Inc.
$55
Takeda Pharmaceuticals U.S.A., Inc.
$54
JAZZ PHARMACEUTICALS INC.
$52
Spectrum Pharmaceuticals Inc.
$50
BeiGene USA, Inc.
$41
Sumitomo Pharma America, Inc.
$37
Bayer Healthcare Pharmaceuticals Inc.
$36
Daiichi Sankyo Inc.
$36
Coherus Biosciences Inc.
$34
TerSera Therapeutics LLC
$33
Dendreon Pharmaceuticals LLC
$32
Genentech USA, Inc.
$31
SOBI, INC
$30
Regeneron Healthcare Solutions, Inc.
$28
ARRAY BIOPHARMA INC
$26
Boston Scientific Corporation
$26
Exelixis Inc.
$24
ACCORD HEALTHCARE, INC.
$23
Agios Pharmaceuticals, Inc.
$17
Mirati Therapeutics, Inc.
$15
SERVIER PHARMACEUTICALS LLC
$14
Eisai Inc.
$13
Top 3 companies account for 29.7% of 2024 payments
All-time payments by company (2018-2024) ›
Takeda Pharmaceuticals U.S.A., Inc.
$6,754
AstraZeneca Pharmaceuticals LP
$591
PFIZER INC.
$288
GlaxoSmithKline, LLC.
$232
Novartis Pharmaceuticals Corporation
$216
SANOFI-AVENTIS U.S. LLC
$199
ABBVIE INC.
$185
E.R. Squibb & Sons, L.L.C.
$183
Seattle Genetics, Inc.
$175
Genmab U.S., Inc.
$134
Merck Sharp & Dohme LLC
$133
Novocure Inc.
$101
Janssen Biotech, Inc.
$100
Seagen Inc.
$95
Merck Sharp & Dohme Corporation
$93
Astellas Pharma US Inc
$85
Celgene Corporation
$78
EISAI INC.
$70
Tempus AI, Inc
$63
Incyte Corporation
$63
Lilly USA, LLC
$60
Stemline Therapeutics Inc.
$55
JAZZ PHARMACEUTICALS INC.
$52
Spectrum Pharmaceuticals Inc.
$50
BeiGene USA, Inc.
$41
Sumitomo Pharma America, Inc.
$37
Bayer Healthcare Pharmaceuticals Inc.
$36
Daiichi Sankyo Inc.
$36
Coherus Biosciences Inc.
$34
TerSera Therapeutics LLC
$33
Dendreon Pharmaceuticals LLC
$32
Genentech USA, Inc.
$31
SOBI, INC
$30
Regeneron Healthcare Solutions, Inc.
$28
ARRAY BIOPHARMA INC
$26
Boston Scientific Corporation
$26
Exelixis Inc.
$24
ACCORD HEALTHCARE, INC.
$23
Agios Pharmaceuticals, Inc.
$17
Mirati Therapeutics, Inc.
$15
SERVIER PHARMACEUTICALS LLC
$14
Eisai Inc.
$13
Top 3 companies account for 72.4% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · ALUNBRIG · AUGTYRO · BOSULIF · BRUKINSA · CABOMETYX · CALQUENCE · CAMCEVI · CARVYKTI · DARZALEX · ENHERTU · EPKINLY · Enhertu · Epkinly · FRUZAQLA · Fabhalta · IBRANCE · IMBRUVICA · IMFINZI · INLYTA · Itovebi · JAKAFI · JEMPERLI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · LIBTAYO · LORBRENA · LUPRON DEPOT · LYNPARZA · Lenvima · MONJUVI · Nubeqa · OJJAARA · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · Oncology · Orserdu · PLUVICTO · PROVENGE · PYRUKYND · REBLOZYL · ROLVEDON · RYBREVANT · SCEMBLIX · Stivarga · TAGRISSO · TALZENNA · TECVAYLI · TIVDAK · Tibsovo · Udenyca · VENCLEXTA · VERZENIO · VONJO · XALKORI · XTANDI · ZEJULA · ZEPZELCA · Zoladex
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (64%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers.

Looking for a hematology specialist in Olympia?
Compare hematologists in the Olympia area by procedure volume, costs, and industry payment transparency.
Browse hematologists nearby

Geographic Context

Hematologists within 10 mi
4
Per 100K population
1.3
County median income
$93,985
Nearest hospital
PROVIDENCE ST PETER HOSPITAL
0.0 mi

Data Sources

Provider Registry ✓ NPPES Weekly updates
Medicare Enrollment ✓ PECOS Monthly updates
Practice Data — No data N/A
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Robertson is a hematology specialist, with consulting-driven industry engagement, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Robertson receive payments from pharmaceutical companies?
Yes. Dr. Robertson received a total of $10,547 from 42 companies across 132 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Robertson) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Same specialty & city
Hematologists in Olympia
Browse hematologists in Olympia ranked by procedure volume and transparency data.
Highest volume
Top Hematologists in WA
Hematologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematologists in WA
Which WA hematologists receive the most from drug and device companies.
By company
Takeda Pharmaceuticals U.S.A., Inc. Payments to Doctors
See all physicians who received payments from Takeda Pharmaceuticals U.S.A., Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →